These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9459923)

  • 21. Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.
    Banerjee A; Talreja A; Sonnenblick EH; LeJemtel TH
    Mt Sinai J Med; 2003 Sep; 70(4):225-31. PubMed ID: 12968195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of angiotensin-converting enzyme inhibitors in patients with congestive heart failure. Same efficacy? Same costs?].
    González-Juanatey JR
    Med Clin (Barc); 1998 Feb; 110(7):278. PubMed ID: 9562957
    [No Abstract]   [Full Text] [Related]  

  • 23. The value of diuretics in chronic heart failure demonstrated by an implanted haemodynamic monitor.
    Erdmann E
    Eur Heart J; 2002 Jan; 23(1):7-9. PubMed ID: 11741355
    [No Abstract]   [Full Text] [Related]  

  • 24. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pharmacologic management of chronic heart failure associated with left ventricular systolic dysfunction.
    Parra D; Marshall R; Soisson K
    Lippincotts Prim Care Pract; 1999; 3(3):316-32. PubMed ID: 10711133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of ACE inhibitors and angiotensin receptor blockers in the treatment and prevention of chronic heart failure].
    Kárpáti P
    Orv Hetil; 2005 May; 146(18):827-31. PubMed ID: 15926627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart failure in women.
    Silber DH
    Curr Womens Health Rep; 2003 Apr; 3(2):104-9. PubMed ID: 12628079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of angiotensin II receptor antagonists in the treatment of patients with chronic heart failure].
    Martynov AI; Vasiuk IuA; Krikunov PV; Khadzagova AB; Iushchuk EN; Sologub KN
    Ter Arkh; 2001; 73(8):84-8. PubMed ID: 11599279
    [No Abstract]   [Full Text] [Related]  

  • 30. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure; the OSCUR study. Oucome dello Scompenso Cardiaco in relazione all'Utilizzo delle Risore.
    Bellotti P; Badano LP; Acquarone N; Griffo R; Lo Pinto G; Maggioni AP; Mattiauda C; Menardo G; Mombelloni P;
    Eur Heart J; 2001 Apr; 22(7):596-604. PubMed ID: 11259147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congestive heart failure in pediatric patients.
    Kay JD; Colan SD; Graham TP
    Am Heart J; 2001 Nov; 142(5):923-8. PubMed ID: 11685182
    [No Abstract]   [Full Text] [Related]  

  • 33. Sex differences in response to chronic heart failure therapies.
    Ghali JK; Lindenfeld J
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):555-65. PubMed ID: 18402544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
    Vonder Muhll I; Liu P; Webb G
    Int J Cardiol; 2004 Dec; 97 Suppl 1():25-33. PubMed ID: 15590076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current role of angiotensin II antagonists in the treatment of heart failure].
    Porcu M; Orrù P
    Ital Heart J Suppl; 2000 Sep; 1(9):1213-4. PubMed ID: 11140296
    [No Abstract]   [Full Text] [Related]  

  • 36. Should we inhibit angiotensin-converting enzymes in acute heart failure?
    Lamond NW; Howlett JG
    Heart Fail Monit; 2007; 5(3):70-6. PubMed ID: 17487295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiotensin converting enzyme inhibitors in the treatment of heart failure].
    Bettencourt P; Ferreira A
    Rev Port Cardiol; 2000 Dec; 19 Suppl 2():II51-6. PubMed ID: 11301911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based drug treatment of heart failure.
    Wasson S; Fleming D; Reddy HK
    Mo Med; 2005; 102(6):540-8; quiz 548-9. PubMed ID: 16355640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure.
    Scow DT; Smith EG; Shaughnessy AF
    Am Fam Physician; 2003 Nov; 68(9):1795-8. PubMed ID: 14620599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.